U.S. RESEARCH ROUNDUP-Bed Bath & Beyond, Blackberry, GMS

Brookfield Renewable Partners LP

28/06/2021 08:36

June 28 (Reuters) - Wall Street securities analysts revised their ratings and price targets
on several U.S.-listed companies, including Bed Bath & Beyond, Blackberry and GMS, on Monday. 
    
    HIGHLIGHTS
     * Bed Bath & Beyond Inc  BBBY.O : CFRA raises to buy from hold rating 
     * Blackberry Ltd  BB.N : CIBC cuts to underperformer from neutral rating    
     * Global Blood Therapeutics Inc  GBT.O : JP Morgan cuts to neutral from overweight     
     * GMS Inc  GMS.N : Stephens raises to overweight from equal-weight rating 
    
Following is a summary of research actions on U.S. companies reported by Reuters on Monday.
Stock entries are in alphabetical order. 
    
     * a of Smith Corp  AOS.N : Jefferies raises price target to $75 from $70 
     * Akumin Inc  AKU.O : National Bank of Canada raises target price to $3.5 from $3.25 
     * Apogee Enterprises Inc  APOG.O : Craig-Hallum raises target price to $48 from $43 
     * Bed Bath & Beyond Inc  BBBY.O : CFRA raises to buy from hold rating 
     * Blackberry Ltd  BB.N : CIBC cuts to underperformer from neutral rating
     * Blackberry Ltd  BB.N : CIBC raises target price to $11 from $9 
     * Brookfield Renewable Partners LP  BEP.N : Credit Suisse raises to outperform from neutral 
     * Carmax Inc  KMX.N : RBC raises target price to $160 from $148 
     * Caseys General Stores Inc  CASY.O : JP Morgan cuts target price to $175 from $179 
     * City Office REIT Inc  CIO.N : RBC raises target price to $14 from $12 
     * Constellation Brands Inc  STZ.N : Jefferies raises price target to $298 from $295 
     * Dlocal Ltd  DLO.O : JP Morgan initiates coverage with neutral rating; target price $48 
     * Fedex Corp  FDX.N : CFRA raises target price to $357 from $342 
     * Global Blood Therapeutics Inc  GBT.O : JP Morgan cuts target price to $36 from $70 
     * Global Blood Therapeutics Inc  GBT.O : JP Morgan cuts to neutral from overweight 
     * GMS Inc  GMS.N : Baird raises to outperform rating; raises target price to $58 from $50 
     * GMS Inc  GMS.N : Stephens raises target price to $56 from $43 
     * GMS Inc  GMS.N : Stephens raises to overweight from equal-weight rating 
     * Huntsman Corp  HUN.N : JP Morgan cuts price target to $30 from $31 
     * Intellia Therapeutics Inc  NTLA.O : Truist Securities raises target to $160 from $80 
     * Intellia Therapeutics Inc  NTLA.O : Wedbush raises target price to $87 from $73 
     * Luminar  LAZR.O : Baird raises to outperform rating; raises target price to $30 from $22 
     * Microsoft  MSFT.O : Jefferies raises price target to $310 from $290 
     * Paychex Inc  PAYX.O : Cowen and Company raises price target to $106 from $96 
     * Paychex Inc  PAYX.O : Credit Suisse raises target price to $115 from $110 
     * Paychex Inc  PAYX.O : JP Morgan raises target price to $105 from $91 
     * Trade Desk  TTD.O : Oppenheimer adjusts PT to $85 from $600 to reflect 10-for-1 stock split 
 
 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))